However, a direct effect of rosiglitazone on PDV tumor cell proliferation is unlikely, as rosiglitazone did not alter Ki67+ PDV tumor cell positivity when tumors were grown in immune deficient NODSCID mice (Figure 5B). Here, MKI67 is linked to neoplasm.